USA FDA approves ANDAs for Plan B One-Step and Trandate


Watson Pharmaceuticals (NYSE: WPI) says its subsidiary Watson Laboratories approval from the US Food…

Cardio-vascularGenericsNorth AmericaPar PharmaceuticalsPlan B One-StepRegulationReproductiveTeva Pharmaceutical IndustriesTrandateWatson Pharmaceuticals

Bayer's Xarelto reimbursement backed in Canada; EMA concludes Yvidually arbitration


The Canadian Agency for Drugs and Technologies in Health (CADTH) through the Common Drug Review (CDR),…

BayerCardio-vascularEuropeNorth AmericaPharmaceuticalPricingRegulationReproductiveXareltoYvidually

Mylan confirms patent challenge to Generess Fe; launches Caduet copy in USA


US generic drug major Mylan (Nasdaq: MYL) yesterday confirmed that it and Famy Care have been sued by…

CaduetCardio-vascularGeneress FeGenericsMarkets & MarketingMylan LaboratoriesNorth AmericaPatentsPfizerReproductiveWarner ChilcottWomen's Health

Pfizer gains six months patent life for Lipitor on pediatric data; Bayer Yasmin patent scotched


US drugs behemoth Pfizer (NYSE: PFE) could extend the European patent term for its al-time blockbuster…


Bayer says US filing for Xarelto delayed; Visanne cleared in Europe


German drug major Bayer announced over the weekend details of data from the EINSTEIN Extension study…

AspirinBayerBayerCardio-vascularEuropeJohnson & JohnsonNorth AmericaNystatinOralPharmaceuticalRegulationReproductive

New anticoagulant studies may change current medical practice including use of aspirin and heparin in VTE and to prevent miscarriages


Research presented yesterday at the 51st Annual Meeting of the American Society of Hematology, now taking…

AspirinBayerBoehringer IngelheimCardio-vascularHamiltonheparinNystatinOralPharmaceuticalReproductive

Back to top